This site is intended for a UK healthcare professional audience and NHS relevant decision makers only. General information about EXJADE®▼ (deferasirox) is also provided in the section for members of the public.



▼ This medicine is subject to additional monitoring. This will allow quick identification of new safety information.

Reporting side effects: If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at By reporting side effects, you can help provide more information on the safety of this medicine.

Patient information leaflet (PIL)

Summary of product characteristics (SmPC)


UK | May 2022 | 213759


Ask Speakers


Medical Information Request

Adverse events should be reported. Reporting forms and information can be found at Adverse events should also be reported to Novartis via [email protected] or online through the pharmacovigilance intake (PVI) tool at
If you have a question about the product, please contact Medical Information on 01276 698370 or by email at m[email protected]